Effect of Pioglitazone on Interleukin-18 and Toll-Like Receptor 4 Expression in OLETF Rats with Insulin Resistance
10.3969/j.issn.0253-9896.2014.06.016
- VernacularTitle:吡格列酮对胰岛素抵抗OLETF大鼠血清IL-18、TLR4表达的影响
- Author:
Liting SUN
;
Zhiqiang ZHAO
;
Fengshi TIAN
- Publication Type:Journal Article
- Keywords:
insulin resistance;
interleukin-18;
toll-like receptor 4;
cardiovascular diseases;
rats,inbred OLETF;
pi-oglitazone
- From:
Tianjin Medical Journal
2014;(6):569-572
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate change of TLR4 in OLETF (Otsuka Long-Evans Tokushima fatty) rats with in-sulin resistance (IR), and to study the effect of pioglitazone (PIO) on the expression of TLR4, and to explore the possible mechanisms of the PIO reducing the risk of cardiovascular diseases. Methods Twenty four OLETF rats were fed with high-fat diet for 20 weeks to establish the IR model then they were randomly assigned into two groups:the model group (group M), in which the rats were fed with high-fat diet;the PIO group (group P), in which the rats were fed with PIO in addition to high-fat diet . Control group include 12 OLETF rats fed with normal diet (group NC). After 20 weeks of drug intervention, plasma levels of FINS (Fasting INSulin), FBG (Fasting Blood Glucose), blood lipid, IL-18 and TLR4 were assessed in every group. Results Comparing with group NC, FBG, Blood lipid, IL-18 and TLR4 were significantly increased in group M(P＜0.05 or P＜0.01), comparing with group M, FBG, Blood lipid were improved in group P, and serum IL-18, TLR4 were signifi-cantly lower in the group P than that in group M(P＜0.05 or P＜0.01). Conclusion TLR4 may be involved in IR by pro-moting inflammatory response, and PIO can significantly improve IR and inflammatory, and reduce the risk of cardiovascular diseases by inhibiting the expression of TLR4.
